Almost 20 years’ worth of follow-up in an international registry shows that patients with degenerative mitral regurgitation who underwent mitral valve (MV) repair had better survival, fewer ...
Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...
Early feasibility data from two studies of valve replacement presented at TCT 2021 show promise for novel transcatheter devices for mitral and tricuspid regurgitation. The Intrepid (Medtronic) ...
Patient will be placed under general anesthesia. An endotracheal tube will be inserted into the patient’s windpipe and connected to a ventilator to assist the patient’s breathing. Another probe will ...
Greg Denning has never really liked going to the doctor, and for most of his life he's been an active person who was able to avoid significant medical care. That started to change one day when he and ...
Edwards Lifesciences is paying up to $690 million to a buy an Israeli company that makes transcatheter mitral valve and tricuspid repair devices. Last year it bought a mitral valve replacement company ...
Research, along with guidelines from the American Heart Association® (AHA), indicates that patients who have primary mitral regurgitation would benefit from mitral valve repair rather than replacement ...
A study published in the New England Journal of Medicine found that compared to mitral valve repair, mitral valve replacement results in a lower rate of heart failure and fewer hospitalizations for ...
Please provide your email address to receive an email when new articles are posted on . The use of a transcatheter mitral valve replacement system appears to be safe and effective in the treatment of ...
CONGENITAL mitral stenosis, sufficiently severe to cause recurrent heart failure and syncopal episodes in infancy, is rarely compatible with life beyond two years of age. 1 Except for 1 reported case ...